Company profile
HCW Biologics Inc.
NASDAQ: HCWB · Healthcare · Biotechnology
#1078 of 1,418 Healthcare companies by revenuebottom-decile growth
EA Score
31DFH 35DQ 26GM 26SS 32
v0.1 · 65/100 weight · provisional
↑ Piotroski F, growth stability · ↓ operating margin, net margin
Methodology →Revenue TTM
$6.7M
Rev growth YoY (TTM)
+707.0%
Net income (FY)
-$8.0M
Employees
35
as of 2026-08-25
Market cap
$803.1k
as of 2026-08-25
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$54.2k$54.2k2025
Net income-$8.0M-$8.0M2025
Operating income-$13.2M-$13.2M2025
Total assets$24.5M$24.5M2025
Liabilities$21.8M$21.8M2025
Equity$2.8M$2.8M2025
Revenue trend
FY2021 – FY2025 · USD
FY21
FY22
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is HCW Biologics Inc.’s revenue?
HCW Biologics Inc. booked $54.2k in FY2025 revenue, contracting 98% year over year — among the slowest-growing Healthcare companies we track, at a -14677.1% net margin.
Peers · Healthcare
Micro Imaging Technology, Inc.——Therma Bright Inc.23DGain Therapeutics, Inc.36DFutureWorld Corp.——Natural Health Farm Holdings Inc.——INmune Bio, Inc.41DNeighbors
Broward →Key facts
CEOHing C. Wong
SectorHealthcare
IndustryBiotechnology
HeadquartersMiramar, FL
ExchangeNASDAQ: HCWB
Employees35
IPO date2021-07-20
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.